After President Donald Trump signed an executive order to transform kidney treatment in the U.S., Humana’s stock price increased to $291.28 July 12. At market close July 12, Humana’s share price was up 10 percent from its closing share on July 8.
The share price marked Humana’s highest gain since Feb. 26, when the price closed at $302.35. That high came at the end of a historic run for the company’s shares, according to Louisville Business First.
Read the full report here.
More articles on payers:
UnitedHealth needs to shore up mental health coverage, plaintiffs argue
Las Vegas hospital will have to contract with Medicare, Medicaid by 2021
Massachusetts residents bought fake health insurance, state says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
